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Chemical syntheses  
 
An overview of the syntheses performed is given in Schemes S1-3. 
 
General. Chemicals were purchased from Sigma-Aldrich, Fluka, Acros and Advanced Chem 
Tech, and were used without further purification. BG-NH2 and BC-NH2 were obtained from 
Covalys Biosciences and used without further purification. The syntheses of the intermediate 
1 and 3 were described previously1. Anhydrous solvents from Sigma-Aldrich were used 
without further treatment and distillation. 1H nuclear magnetic resonance (NMR) spectra were 
recorded on a Bruker DPX 400 (400.13 MHz), with chemical shifts (δ) reported in ppm 
relative to the solvent residual signals of CD3OD (3.31 ppm), coupling constants reported in 
Hz. Mass spectra were recorded on a Shimazu Axima CFRplus Maldi-TOF MS. High 
resolution mass spectra (HRMS) were measured on a Micromass Q-TOf Ultima spectrometer 
with electron spray ionization (ESI). Reversed phase analytical HPLC was run on a Waters 
2790 separation module and products were detected at 254 nm and 280 nm using a 2487 dual 
λ absorption detector. The standard gradient used for the purifications was: starting at 5% 
acetonitrile for 2 minutes and raising to 100% acetonitrile within 25 minutes. After 5 min at 
100% acetonitrile, the column was equilibrated for 2 min with 5% acetonitrile. All HPLC 
solvents contained TFA at 0.1% v/v. A 3.9 × 300 mm Prep Nova-Pak HR C18 6 µm column 
from Waters was used to determine the purity of the products. Preparative HPLC was 
performed on a Waters 600 controller and with a Waters 2487 dual λ absorption detector 
using a SunFire™ Prep C18 OBD™ 5 µm 19×150 mm column.  
 
Synthesis of SC-Cy5. To a solution of compound 1 (20 mg, 0.04 mmol), PyBOP (13 mg, 
0.025 mmol) and HOBt (3 mg, 0.025 mmol) in DMF (1 mL), DIPEA (3 mg, 0.025 mmol) and 
BG-NH2 (7 mg, 0.025 mmol) were added at room temperature and stirred overnight. The 
solvent was evaporated to dryness in vacuo. The crude product was purified by preparative 
HPLC to give after lyophilization the product 2 as a blue powder in 32% yield. To a solution 
of compound 2 (5.4 mg, 7.2 µmol), DIC (2.6 mg, 0.025 mmol) and HOBt (3 mg, 0.025 mmol) 
in DMF (1 mL), BC-NH2 (2.5 mg, 0.01 mmol) was added at room temperature and stirred 
overnight. The solvent was evaporated to dryness in vacuo. The crude product was purified by 
preparative HPLC to give after lyophilization the product SC-Cy5 as a blue powder in 85% 
yield. 1H-NMR (400MHz, CD3OD): δ 8.25 (2H, m), 7.85 (2H, m), 7.42-7.22 (12H, m), 7.05 
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(4H, m), 6.60 (1H, t, J = 12 Hz) 6.35 (2H, m), 6.17 (1H, d, J = 8 Hz), 5.48 (2H, s), 5.25 (2H, 
s), 4.43 (4H, m), 4.26 (4H, s), 2.74 (4H, m), 1.55 (6H, s), 1.50 (6H, s). ESI-HRMS calcd for 
[M+H]+ 964.4868, found m/e 964.4860. 
 
Synthesis of SS-Cy5. To a solution of compound 1 (10 mg, 0.02 mmol), PyBOP (26 mg, 0.05 
mmol) and HOBt (3 mg, 0.025 mmol) in DMF (1 mL), DIPEA (7.8 mg, 0.06 mmol) and BG-
NH2 (13.5 mg, 0.05 mmol) were added at room temperature and stirred for 5h. The solvent 
was evaporated to dryness in vacuo. The crude product was purified by preparative HPLC to 
give after lyophilization the product SS-Cy5 as a blue powder in 40% yield (8 mg). 1H-NMR 
(400MHz, CD3OD): δ 8.21 (2H, t, J = 12 Hz,), 7.75 (2H, s), 7.39-7.20 (12H, m), 6.97 (4H, d, 
J = 8 Hz), 6.58 (1H, t, J = 12Hz), 6.29 (2H, t, J = 12 Hz), 5.49 (2H, s), 4.42 (4H, m), 4.23 (4H, 
s), 2.71 (4H, m), 1.45 (12H, s). ESI-HRMS calcd for [M+H]2+ 502.7500, found m/e 502.7508 
 
Synthesis of compound 4. A solution of compound 3 (0.9 g, 3.87 mmol) in pyridine (8 ml) 
was heated to reflux. Triethylorthoformate (1.35 ml, 7.76 mmol) was added slowly. The 
solution was heated for 2h. The mixture was dissolved in CH2Cl2 and washed with 0.1 M HCl. 
After removal of the solvent in vacuo, the residue was dissolved in NH3.aq (pH 11) and 
washed with CH2Cl2. pH was adjusted to 1-2 and the desired compound was extracted with 
CH2Cl2. The organic layer was dried over Na2SO4 and concentrated in vacuo. The compound 
4 was obtained as a red powder in 13% yield (236 mg) and was used without further 
purification. 1H-NMR (400MHz, CD3OD): δ 8.58 (1H, t, J = 12Hz), 7.54 (2H, d, J = 8Hz), 
7.48 (2H, t, J = 8Hz), 7.41 (2H, d, J = 8Hz), 7.34 (2H, d, J = 8Hz), 6.49 (2H, t, J = 12 Hz), 
4.46 (4H, t, J =8Hz), 2.87 (4H, t, J = 8Hz), 1.79(12H, s).  
 
Synthesis of SS-Cy3. A solution of compound 4 (5 mg, 0.01 mmol), BG-NH2(10 mg, 0.04 
mmol), DIEA(3 mg, 0.02 mmol) and PyBOP (10 mg, 0.02 mmol) in dry DMF (1 ml) was 
stirred for 5h at room temperature. The crude product was purified by preparative HPLC to 
give after lyophilization the compound SS-Cy3 as a red powder in 26% yield (2.5 mg). 1H-
NMR (400MHz, CD3OD): δ 8.33 (1H, t, J = 12 Hz), 7.90 (2H, s), 7.44-7.29 (12H, m), 6.95 
(4H, d, J = 8 Hz), 6.38 (2H, d, J = 12 Hz), 5.51 (4H, s), 4.44 (4H, m), 4.24 (4H, s), 2.75 (4H, 





Scheme S1: Synthesis of SC-Cy5. (a) PyBOP, HOBt, DIPEA, DMF, room temperature, 
overnight, 32% yield; (b) DIC, HOBt, DMF, room temperature, overnight, 85% yield. 
 
 
Scheme S2: Synthesis of SS-Cy5. (a) PyBOP, HOBt, DIPEA, DMF, room temperature, 5 
hours, 40% yield. 
 
 
Scheme S3: Synthesis of SS-Cy3. (a) Triethylorthoformate, pyridine, reflux, 2 hours, 13% 






Table S1. For each experiment the lysis buffer, the quantity of extract loaded on gel and the 





extract loaded on 
gel (µg) 
Fusion proteins Conc. of fusion 
protein in extract 
(nM) 
Conc. of fusion 
protein in extract 
(pmol/mg) 
Figure 3a/3b 1 50 SNAP-FKBP 130 20 
   CLIP-FRB 115 17 
      
Figure 3d/3e 1 40 SNAP-FKBP 350 65 
      
Figure 4a 1 40 SNAP-FKBP 120 22 
   CLIP-FRB 100 19 
      
Figure 4c 2 20 SNAP-FKBP 25 10 
   CLIP-FRB 20 7.5 
   CLIP-ALK5 25 10 
      
Figure 5a 1 50 SNAP-Mdm2 20 3 
   CLIP-p53 40 6 
      
Figure 5c 1 65 SNAP-p53 10 1.4 
   SNAP-Mdm2 6 2.3 
      
Figure 5d 2 90 SNAP-p53 8 1.5 
   SNAP-p53Δ 20 3.3 
      
Figure 5e 2 65 SNAP-p53Δ 8 2 
   CLIP-Mdm2 6 1.5 
      
Figure 6a 2 30 SNAP-FKBP-F36M 250 62.5 
      
Figure 7b 2 35 SNAP-MEK1 (lane1) 120 25 
   ERK2-CLIP (lane 1) 120 25 
   SNAP-MEK1 (lane 2) 150 32 
   CLIP-FKBP (lane 2) 150 32 
   SNAP-FKBP (lane3) 170 36 
   ERK2-CLIP (lane 3) 50 10 
   SNAP-MEK1 (lane 4) 70 15 
   ERK2-CLIP (lane 4) 50 10 
   SNAP-FKBP (lane 4) 130 28 






Figure S1. Kinetic study of the inter- and intramolecular crosslinking reactions. (a) 
Determination of k1 and k3 (see Figure 2a). Reaction progress curves of the labeling 
(represented by the normalized fluorescence) of recombinant SNAP-FKBP (0.2 µM) and 
CLIP-FRB (0.2 µM) with 2 µM of SC-Cy5. Data represent the mean ± SD of two 
independent experiments. Data were fitted with a pseudo-first order rate model. (b) 
Determination of k2 and k4 (see Figure 2a). Reaction progress curves of the reactions of 
purified SNAP-FKBP-Cy5-BC (0.25 µM) with CLIP-FKBP (5 µM), and purified CLIP-FRB-
Cy5-BG (0.25 µM) with SNAP-FKBP (5 µM). Data represent the mean ± SD of two 
independent experiments. Data were fitted with a pseudo-first order rate model. (c) 
Determination of k’1, k’2, k’3 and k’4 (see Figure 2b). Recombinant SNAP-FKBP (0.2 µM) and 
CLIP-FRB (0.2 µM) treated with rapamycin (5 µM) were incubated with different 
concentration of SC-Cy5 (1, 2, 4, 6 and 10 µM) for different times. The graph shows the 
percentages (values of two independent experiments) of formed SNAP-FKBP-CLIP-FRB, 
labeled CLIP-FRB and labeled SNAP-FKBP as a function of time for the different 
concentration of SC-Cy5. Data were fitted with a kinetic model described in Figure 2b using 
script given in Annex 1. 
 
 
Figure S2. Reactions of recombinant SNAP-FKBP (0.2 µM) and CLIP-FRB (0.2 µM) with 2 
µM of SC-Cy5 in presence of 0 µM (a,b) or 5 µM (c,d) of rapamycin. (a, c) Analysis of the 
crosslinking reaction by SDS-PAGE and in-gel fluorescence scanning (NB: SNAP-FKBP 
appears as a double band on the gels). (b, d) Reaction progress curves. Data represents mean 
± SD of two independent experiments. For clarity, in this figure the names of the crosslinked 






Figure S3. Crosslinking of a weak homodimer; the FKBP-F36M homodimer as an example. 
(a) Kinetic scheme for the crosslinking of a dimeric SNAP-tag fusion protein using SS-Cy5. 
For simplicity, all the reactions leading to an intermolecular crosslinking are described with 
the same rate constant k3; all the reactions leading to labeling of SNAP-tag with SS-Cy5 are 
described with the same rate constant k1. (b) Calculated crosslinking efficiency after 60 min 
of reaction as function of the effective molarity (Meff = k2/k3) and protein concentration while 
fixing KD = 30 µM and [SS-Cy5] = 1 µM. The multi-color surface represents the crosslinked 
product resulting from intramolecular crosslinking (step with rate constant k2; see script in 
Annex 2). The red surface represents the product resulting from intermolecular crosslinking 
(steps with rate constant k3; see script in Annex 3). The scheme described in (a) was used for 
the simulation with the following rate constants: kon was fixed to 10 µM-1min-1; koff was fixed 
to 300 min-1; k1 was fixed to 0.036 µM-1min-1, the rate constant of the reaction of SNAP-
FKBP with the crosslinker determined experimentally in cell lysate (data not shown); k3 was 
fixed to 0.01 µM-1min-1, the rate constant of the intermolecular crosslinking with SNAP-
FKBP monomer determined experimentally in vitro (rate constant k4 in Figure 2). The 
calculation showed that a weak interaction with a KD of 30 µM can be efficiently crosslinked 
only when both the protein concentration in the cell extract and Meff are high; the drop of one 
of these two parameters or of both leads to a drastic decrease of the crosslinking efficiency. 
(c) Two-dimensional cut of (b) at protein concentration of 250 nM (i.e. FKBP-F36M 
concentration used in experiment). The green line represents the specific signal, the red line 
represents the unspecific signal and the black line represents the sum of the two. As can be 
seen from the graph, the observed crosslinking efficiency for SNAP-FKBP-F36M requires an 
effective molarity of 500 µM. This value was obtained by fitting the dependence of SNAP-
FKBP-F36M crosslinking efficiency on protein concentration with the model described in (a) 
(see script in Annex 4). (d) Comparison of structures of FKBP-F36M homodimer (PDB Id: 
1EYM) and FKBP-Rapamycin-FRB (PDB Id: 1NSG) heterodimer. The higher effective 
9 
 
molarity value predicted from (c) is consistent with the shorter distance between the N-
termini in the homodimer of FKBP-F36M (38 Å) compared to the FKBP-FRB heterodimer 















 (1) Brun, M. A.; Tan, K. T.; Nakata, E.; Hinner, M. J.; Johnsson, K. J. Am. Chem. 





Annex 1. DYNAFIT script used for the determination of the rate constants k’1, k’2, k’3 and k’4 
of the intramolecular crosslinking process (see Figure S1c). 
 
[task] 
task = fit 
data = progress 
 
[mechanism] 
P  + S -> PSX      : k1 
P  + S -> PSY      : k3 
PSX -> PD          : k2 
PSY -> PD          : k4 
PSX + S -> PSS     : k3 
PSY + S -> PSS     : k1 
 
[constants] 
k1 = 0.1 ?    ; µM-1min-1 
k2 = 0.1 ?    ; min-1 
k3 = 0.01 ?   ; µM-1min-1 
k4 = 1 ?      ; min-1 
     
[concentrations] 
P  = 0.2  ; µM 
 
[progress] 
directory      C:\ 
extension      txt 
file      PS1 
conc. S = 1  
response PD = 0, PSY = 0, PSX = 426208, PSS = 301897 
file      PS2 
conc. S = 2  
response PD = 0, PSY = 0, PSX = 426208, PSS = 301897 
file      PS3 
conc. S = 4  
response PD = 0, PSY = 0, PSX = 426208, PSS = 301897 
file      PS4 
conc. S = 6  
response PD = 0, PSY = 0, PSX = 426208, PSS = 301897 
file      PS5 
conc. S = 10  
response PD = 0, PSY = 0, PSX = 426208, PSS = 301897 
file      PSS1 
conc. S = 1  
response PD = 0, PSY = 0, PSX = 0, PSS = 301897 
file      PSS2 
conc. S = 2  
response PD = 0, PSY = 0, PSX = 0, PSS = 301897 
file      PSS3 
conc. S = 4  
response PD = 0, PSY = 0, PSX = 0, PSS = 301897 
file      PSS4 
conc. S = 6  
response PD = 0, PSY = 0, PSX = 0, PSS = 301897 
file      PSS5 
conc. S = 10  
response PD = 0, PSY = 0, PSX = 0, PSS = 301897 
file      PD1 
conc. S = 1  
response PD = 576244, PSY = 0, PSX = 0, PSS = 0 
file      PD2 
conc. S = 2  
response PD = 576244, PSY = 0, PSX = 0, PSS = 0 
file      PD3 
conc. S = 4  
response PD = 576244, PSY = 0, PSX = 0, PSS = 0 
file      PD4 
conc. S = 6  
response PD = 576244, PSY = 0, PSX = 0, PSS = 0 
file      PD5 
conc. S = 10  





 Annex 2. DYNAFIT script used for the simulation of the signal generated by the crosslinking 
of interacting proteins (PD) (see Figure S3a,b).  
 
[task] 
task = simulate 




;-----------------------------main crosslinking reactions------------------------------------- 
 
SX + SX <-> SXSX       : kon koff  ; main equilibrium  
SX + L -> SXL          : k1        ; labeling of monomer 
SXL + SXL <-> SXLSXL   : kon koff  ; equilibrium of labeled monomers   
SX + SXL <-> SXSXL     : kon koff  ; equilibrium of labeled and unlabeled monomers  
SXSXL -> PD            : k2        ; specific crosslinking 
SXSXL + L -> SXLSXL    : k1        ; second step of labeling of dimer 
SXSX + L -> SXSXL      : k1        ; first step of labeling of dimer 
SXL + SX -> FALSE      : k3        ; Unspecific crosslinking 
 
;-----------------------------Dimer-monomer unspecific crosslinking--------------------------- 
 
   SXSX + SXL -> SXFALSE    : k3  
   SX + FALSE <-> SXFALSE   : kon koff 
   SXSXL + SX -> SXFALSE    : k3 
   SXSXL + SXL -> SXLFALSE  : k3 
   SXL + FALSE <-> SXLFALSE : kon koff 
   SXLSXL + SX -> SXLFALSE  : k3 
 
[constants] 
kon = 10          ; µM-1min-1  
koff = 300        ; min-1  
k1  = 0.036       ; µM-1min-1  
k2  = 0.01        ; min-1  




SX = 0.001 ; µM 
L = 1  ; µM 
 
[responses] 
PD = 200000 ; 2*100/[SX] 
 
[sweep] 




extension      txt 







;task done for:  





Annex 3. DYNAFIT script used for the simulation of the signal generated by the crosslinking 
of non-interacting proteins (FALSE) (see Figure S3a,b). 
 
[task] 
task = simulate 




;-----------------------------main crosslinking reactions------------------------------------- 
 
SX + SX <-> SXSX       : kon koff  ; main equilibrium  
SX + L -> SXL          : k1        ; labeling of monomer 
SXL + SXL <-> SXLSXL   : kon koff  ; equilibrium of labeled monomers   
SX + SXL <-> SXSXL     : kon koff  ; equilibrium of labeled and unlabeled monomers  
SXSXL -> PD            : k2        ; specific crosslinking 
SXSXL + L -> SXLSXL    : k1        ; second step of labeling of dimer 
SXSX + L -> SXSXL      : k1        ; first step of labeling of dimer 
SXL + SX -> FALSE      : k3        ; Unspecific crosslinking 
 
;-----------------------------Dimer-monomer unspecific crosslinking--------------------------- 
 
   SXSX + SXL -> SXFALSE    : k3  
   SX + FALSE <-> SXFALSE   : kon koff 
   SXSXL + SX -> SXFALSE    : k3 
   SXSXL + SXL -> SXLFALSE  : k3 
   SXL + FALSE <-> SXLFALSE : kon koff 
   SXLSXL + SX -> SXLFALSE  : k3 
 
[constants] 
kon = 10          ; µM-1min-1  
koff = 300        ; min-1  
k1  = 0.036       ; µM-1min-1  
k2  = 0.01        ; min-1  




SX = 0.001 ; µM 
L = 1  ; µM 
 
[responses] 
FALSE =200000 ; 200/[SX] 
 
[sweep] 




extension      txt 





;task done for:  





Annex 4. DYNAFIT script used for the fitting of the experimentally determined crosslinking 
efficiencies of FKBP-F36M homodimer (see Figure S3c). 
 
[task] 
task = fit 




;-----------------------------main crosslinking reactions------------------------------------- 
 
SX + SX <-> SXSX       : kon koff  ; main equilibrium  
SX + L -> SXL          : k1        ; labeling of monomer 
SXL + SXL <-> SXLSXL   : kon koff  ; equilibrium of labeled monomers   
SX + SXL <-> SXSXL     : kon koff  ; equilibrium of labeled and unlabeled monomers  
SXSXL -> PD            : k2        ; specific crosslinking 
SXSXL + L -> SXLSXL    : k1        ; second step of labeling of dimer 
SXSX + L -> SXSXL      : k1        ; first step of labeling of dimer 
SXL + SX -> FALSE      : k3        ; Unspecific crosslinking 
 
;-----------------------------Dimer-monomer unspecific crosslinking--------------------------- 
 
   SXSX + SXL -> SXFALSE    : k3  
   SX + FALSE <-> SXFALSE   : kon koff 
   SXSXL + SX -> SXFALSE    : k3 
   SXSXL + SXL -> SXLFALSE  : k3 
   SXL + FALSE <-> SXLFALSE : kon koff 




kon  = 10         ; µM-1min-1 
koff = 300        ; min-1 
k1  = 0.036       ; µM-1min-1  
k2  = 4 ?         ; min-1 
k3  = 0.01        ; µM-1min-1 
 
[concentrations] 
L = 1  ; µM 
 
[responses] 
PD = 1  
FALSE = 1  
 
[progress] 
directory      C:\data\ 
extension      txt 
file 1, 2, 3, 4 
vary conc. SX = 0.002, 0.02, 0.2, 0.25 
 
[output] 
directory C:\output\ 
 
[end] 
 
 
